From Bench To Bedside
Clinical trials are necessary to obtain or expand our knowledge about the efficacy and tolerability of medicinal products. Therefore, the legislature has stipulated that new medicinal products must be clinically tested. As required by law, the TRACE trial has been approved by the responsible authority and has been issued a favourable opinion by independent ethics committees.
TRACE ("TRansfer of Adenovirus, Cytomegalovirus and Epstein-Barr virus-specific T cells") is
- Phase III
- randomized Placebo-controlled and
- Double-blind
The TRACE trial will be conducted in 18 clinical centres of five European countries: Belgium, France, Germany, Italy and the Netherlands. A total of approximately 150 children as well as adults are expected to participate. The study is coordinated by the Medical Center - University of Freiburg (Sponsor) and was funded by the European Commission.